CN114158621A - Composition of wolfberry fruit oil and walnut oil and application thereof - Google Patents
Composition of wolfberry fruit oil and walnut oil and application thereof Download PDFInfo
- Publication number
- CN114158621A CN114158621A CN202111509884.XA CN202111509884A CN114158621A CN 114158621 A CN114158621 A CN 114158621A CN 202111509884 A CN202111509884 A CN 202111509884A CN 114158621 A CN114158621 A CN 114158621A
- Authority
- CN
- China
- Prior art keywords
- oil
- composition
- walnut
- protein peptide
- walnut oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003921 oil Substances 0.000 title claims abstract description 35
- 235000019198 oils Nutrition 0.000 title claims abstract description 35
- 235000013399 edible fruits Nutrition 0.000 title claims abstract description 33
- 235000019498 Walnut oil Nutrition 0.000 title claims abstract description 30
- 239000008170 walnut oil Substances 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- 235000015468 Lycium chinense Nutrition 0.000 title claims abstract description 14
- 235000015459 Lycium barbarum Nutrition 0.000 title claims description 13
- 244000241838 Lycium barbarum Species 0.000 title claims 9
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 39
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 33
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 33
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 22
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 22
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 22
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 22
- 230000000694 effects Effects 0.000 claims abstract description 22
- 230000002929 anti-fatigue Effects 0.000 claims abstract description 17
- 102000004190 Enzymes Human genes 0.000 claims abstract description 9
- 108090000790 Enzymes Proteins 0.000 claims abstract description 9
- 102000004142 Trypsin Human genes 0.000 claims abstract description 7
- 108090000631 Trypsin Proteins 0.000 claims abstract description 7
- 239000012588 trypsin Substances 0.000 claims abstract description 6
- 235000013372 meat Nutrition 0.000 claims abstract description 5
- 230000002255 enzymatic effect Effects 0.000 claims description 4
- 239000000413 hydrolysate Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000013355 food flavoring agent Nutrition 0.000 claims description 3
- 235000003599 food sweetener Nutrition 0.000 claims description 3
- 239000003765 sweetening agent Substances 0.000 claims description 3
- 235000011194 food seasoning agent Nutrition 0.000 claims 1
- 208000003464 asthenopia Diseases 0.000 abstract description 14
- 239000002904 solvent Substances 0.000 abstract description 11
- 244000241872 Lycium chinense Species 0.000 abstract description 9
- 238000002360 preparation method Methods 0.000 abstract description 6
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 235000013376 functional food Nutrition 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000012528 membrane Substances 0.000 description 10
- 238000000605 extraction Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical compound OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 238000010828 elution Methods 0.000 description 5
- 229920001184 polypeptide Polymers 0.000 description 5
- 238000010008 shearing Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 230000009182 swimming Effects 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 241000758789 Juglans Species 0.000 description 3
- 235000009496 Juglans regia Nutrition 0.000 description 3
- 239000001273 butane Substances 0.000 description 3
- 229940095066 hydroxytyrosol Drugs 0.000 description 3
- 235000003248 hydroxytyrosol Nutrition 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 208000001491 myopia Diseases 0.000 description 3
- 230000004379 myopia Effects 0.000 description 3
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 3
- 238000005086 pumping Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- 235000020234 walnut Nutrition 0.000 description 3
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 2
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 2
- 239000010779 crude oil Substances 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000001728 nano-filtration Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- KEQXNNJHMWSZHK-UHFFFAOYSA-L 1,3,2,4$l^{2}-dioxathiaplumbetane 2,2-dioxide Chemical compound [Pb+2].[O-]S([O-])(=O)=O KEQXNNJHMWSZHK-UHFFFAOYSA-L 0.000 description 1
- XXMFJKNOJSDQBM-UHFFFAOYSA-N 2,2,2-trifluoroacetic acid;hydrate Chemical compound [OH3+].[O-]C(=O)C(F)(F)F XXMFJKNOJSDQBM-UHFFFAOYSA-N 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 206010011026 Corneal lesion Diseases 0.000 description 1
- 208000003164 Diplopia Diseases 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 206010015967 Eye swelling Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020675 Hypermetropia Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 208000029091 Refraction disease Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- XBJFCYDKBDVADW-UHFFFAOYSA-N acetonitrile;formic acid Chemical compound CC#N.OC=O XBJFCYDKBDVADW-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000004430 ametropia Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000029444 double vision Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- HQVFCQRVQFYGRJ-UHFFFAOYSA-N formic acid;hydrate Chemical compound O.OC=O HQVFCQRVQFYGRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000002013 hydrophilic interaction chromatography Methods 0.000 description 1
- 201000006318 hyperopia Diseases 0.000 description 1
- 230000004305 hyperopia Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000019476 oil-water mixture Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 210000004896 polypeptide structure Anatomy 0.000 description 1
- -1 preferably Substances 0.000 description 1
- 201000010041 presbyopia Diseases 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 208000014733 refractive error Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/02—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by the production or working-up
- A23D7/04—Working-up
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/02—Pretreatment
- C11B1/04—Pretreatment of vegetable raw material
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/06—Production of fats or fatty oils from raw materials by pressing
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/10—Production of fats or fatty oils from raw materials by extracting
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/001—Refining fats or fatty oils by a combination of two or more of the means hereafter
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/16—Refining fats or fatty oils by mechanical means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Mechanical Engineering (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the technical field of functional food preparation, in particular to a composition of medlar fruit oil and walnut oil and application thereof; the composition comprises medlar oil and walnut oil in any proportion, and protein peptide with anti-fatigue effect is also added in the composition; according to the invention, the medlar oil and the walnut oil are used in a matching manner, and the prepared composition has the function of relieving asthenopia. Meanwhile, the tuna meat is subjected to enzymolysis by using a compound enzyme of Alcalase2.4 enzyme and trypsin to prepare the protein peptide with the anti-fatigue function, and the prepared protein peptide is added into a solvent prepared from the Chinese wolfberry fruit oil and the walnut oil, so that the prepared product has the effect of resisting asthenopia and also has the effect of relieving fatigue.
Description
Technical Field
The invention belongs to the technical field of functional food preparation, and particularly relates to a composition of wolfberry fruit oil and walnut oil and application thereof.
Background
Asthenopia refers to eye fatigue caused by excessive use of eyes while working or learning at close distances. This condition is often experienced by people who are engaged in close-range precision work, computer work, or study or work in environments with poor lighting conditions (too bright/too dark light), and who suffer from ametropia such as myopia, hyperopia, presbyopia, and physical weakness. The symptoms of asthenopia include asthenopia, dry eye, foreign body sensation, heavy eyelid, blurred vision, photophobia, lacrimation, eye swelling and pain, hyperemia of eyes, etc., severe patients also have general symptoms such as headache, dizziness, nausea, listlessness, attention deficit, memory loss, inappetence, etc., a few patients have double vision, stereoscopic vision dysfunction, increased intraocular pressure, corneal lesion, etc., and teenagers also have myopia or deepened myopia. The glaucoma, eye surface or anterior segment disease patients can also cause or aggravate the original eye diseases due to the over-fatigue of eyes, so that the vision fatigue is relieved, which is always a research hotspot.
At present, a lot of students do a lot of work on the aspect of relieving asthenopia, but various measures for relieving asthenopia have unsatisfactory effects, and certain side effects exist in the developed traditional Chinese medicines, chemical medicines and the like with the asthenopia resisting effect after long-term administration.
Disclosure of Invention
The invention aims to provide a composition of Chinese wolfberry fruit oil and walnut oil and application thereof, wherein the Chinese wolfberry fruit oil and the walnut oil have the function of relieving asthenopia; the added protein peptide has the function of resisting fatigue, thereby making up the defects of the prior art.
The invention firstly provides a composition of medlar fruit oil and walnut oil, wherein the composition comprises the medlar fruit oil and the walnut oil in any proportion;
furthermore, the composition is also added with protein peptide with anti-fatigue effect;
the protein peptide with the anti-fatigue effect is obtained by centrifuging enzymolysis liquid of Alcalase2.4 enzyme and trypsin of tuna meat as a specific description of an embodiment;
the enzymolysis liquid is subjected to enzymolysis for 5 to 6 hours at the enzymolysis temperature of 35 ℃;
wherein the enzyme activity ratio of Alcalase2.4 enzyme to trypsin is 1: 3;
further, the molecular weight of the protein peptide is 500-3000 Da.
The protein peptide has the amino acid sequence of YYMEGDFAFGDNY.
Furthermore, the composition also comprises common flavoring agents, preferably, sweetening agents or souring agents;
the invention also provides an anti-fatigue product prepared by the preparation method of the technical scheme.
According to the invention, the medlar oil and the walnut oil are used in a matching manner, and the prepared composition has the function of relieving asthenopia. Meanwhile, the tuna meat is subjected to enzymolysis by using a compound enzyme of Alcalase2.4 enzyme and trypsin to prepare the protein peptide with the anti-fatigue function, and the prepared protein peptide is added into a solvent prepared from the Chinese wolfberry fruit oil and the walnut oil, so that the prepared product has the effect of resisting asthenopia and also has the effect of relieving fatigue.
Drawings
FIG. 1: HPLC profile of 50% ethanol eluted fraction;
FIG. 2: purifying and detecting the eluate for 30-32 min;
FIG. 3: graph of the effect of different doses of PA1 polypeptide on the weight-bearing swimming time of mice.
Detailed Description
The invention adds the protein peptide with the anti-fatigue function into the solvent prepared from the medlar fruit oil and the walnut oil, so that the prepared edible product has the efficacy of resisting asthenopia and also has the effect of relieving fatigue.
The present invention will be described in detail with reference to the following examples and accompanying drawings
Example 1: method for preparing medlar fruit oil
The preparation method of the medlar fruit oil comprises the following steps:
(1) selecting high-quality medlar without broken particles and full fruits, placing the medlar in a low-temperature pulverizer for pulverizing, sieving the medlar by a 40-mesh sieve, weighing 5kg of the obtained medlar powder, placing the medlar powder into an extraction cloth bag, tying a mouth, placing the medlar powder into a closed extraction tank of subcritical extraction equipment, closing a feeding channel, vacuumizing to-0.075 MPa, pumping 20L of butane, heating to 35 ℃, extracting under the extraction pressure of 0.5MPa and the ultrasonic frequency of 15KHz for 25min, and extracting for 3 times;
(2) and after extraction is finished, pumping the extraction solvent into a separation tank, starting a vacuum pump, reducing the pressure of the separation tank to-0.06 MPa, keeping the temperature at 35 ℃, evaporating butane in the material, compressing the gasified butane into a liquid state by a diaphragm compressor, refluxing into the solvent tank, closing the vacuum pump to enable the pressure of the separation tank to reach 0MPa, and discharging the wolfberry fruit oil from a purification port to obtain the wolfberry fruit oil.
The medlar fruit oil used by the invention can adopt any commercially available medlar fruit oil product.
Example 2 method for preparing walnut oil
(1) Cleaning fresh oil walnut, pulverizing to 20 mesh, adding purified water at 40 deg.C 4 times of fresh fruit, and stirring;
(2) further crushing and extracting the cell tissues in the pulp in the step (1) by high-speed shearing, wherein the high-speed shearing rotation speed is 12000r/min, the extraction time is 8min, and the interval is 0.5min every 2min of extraction;
(3) fusing the pulp aqueous solution after high-speed shearing and crushing by using a stirrer to form pulp, and heating, preserving heat and stirring at the temperature of 35 ℃;
(4) then squeezing the fruit pulp in the step (3) at normal temperature;
(5) performing solid-liquid separation on the squeezed pulp by using a high-speed centrifuge (the rotating speed of the high-speed centrifuge is 3000r/min, the time is 25min), separating pomace, and further filtering the oil-water mixed solution by using a 200-mesh filter membrane;
(6) adding sodium chloride accounting for 2 percent of the weight of the oil-water mixture into the oil-water mixed solution, and stirring to completely dissolve the sodium chloride;
(7) standing for 25min, and performing oil-water separation to obtain high-content hydroxytyrosol-rich walnut crude oil and fruit water;
(8) standing the walnut crude oil rich in the high-content hydroxytyrosol to obtain the walnut oil rich in the hydroxytyrosol.
Example 3: preparation of protein peptide with anti-fatigue function
1. Preparation of protein peptides
Adding 5L of purified water into fresh tuna meat, shearing for 30min by using a high-speed shearing machine, transferring to an extraction tank, adding 2g of Alcalase2.4 enzyme and 6g of trypsin, and carrying out enzymolysis at 35 ℃; stirring for enzymolysis reaction for 6 h; then, the mixture was centrifuged by a tubular centrifuge at 10000rpm to obtain an enzymatic hydrolysate.
And (3) firstly pumping the supernatant obtained after the centrifugation of the enzymolysis product into an ultrafiltration membrane with the molecular weight of 3000Da for ultrafiltration, controlling the membrane-passing temperature to be below 25 ℃, controlling the flow rate to be 50mL/min and the pressure to be 15bar, and collecting the enzymolysis liquid penetrating through the membrane. And (3) allowing the enzymatic hydrolysate passing through the first filter membrane (ultrafiltration membrane) to pass through a second filter membrane (nanofiltration membrane) nanofiltration membrane with the molecular weight of 500Da, controlling the membrane passing temperature at 30 ℃ and the pressure at 25bar, directly spray-drying the enzymatic hydrolysate intercepted by the membrane system to obtain milk white powder as protein peptide solid, subpackaging the obtained protein peptide solid with aluminum foil bags, and sterilizing the protein peptide solid in a Co-60 radiation sterilization device for 3 hours to obtain the finished product of the protein peptide.
2. Protein peptide purification
Preparing the prepared protein peptide into a 100mg/ml solution, adsorbing by macroporous adsorption resin, and eluting by pure water, 10% ethanol, 25% ethanol, 50% ethanol, 75% ethanol and 95% ethanol respectively to obtain 6 elution components. The 6 eluted fractions were each tested for Nitric Oxide Synthase Activity (Nitric Oxide Synthase Activity Assay kit, Colorimetric). The test result shows that the 50% ethanol elution component has the best activity.
Separating the 50% ethanol elution component by using HPLC again, wherein the separation conditions are as follows: the instrument comprises the following steps: agilent1260 type high performance liquid chromatograph, chromatographic column: eilit SimoChrom ODS-BP5 μm (4.6 mm. times.250 mm), mobile phase: methanol and 0.1% TFA water, flow rate: 1ml/min, detection wavelength: 220nm, collecting eluate at different time intervals (FIG. 1), and detecting the activity of the eluate for 30-32 min.
3. HPLC analysis of functional protein peptides
Subjecting 30-32min eluate to high performance liquid chromatography C18The analytical column again purified the 30% methanol elution peak with the best results, resulting in a purer single peak (fig. 2), allowing the isolated sample to be of a purity that allows sequencing.
4. Protein peptide structure identification
And (3) carrying out polypeptide structure identification on the purified protein peptide, wherein the chromatographic conditions are as follows: instrument type: LCMS-9030Q-TOF quadrupole-time of flight mass spectrometer, chromatography column: inertsil HILIC C18 reverse phase chromatography column 150 mm. times.3.0 mm, 3 μm, Shimadzu, Japan), column temperature: 30 ℃, injection volume: 1.0 μ L; mobile phase: a is 0.1% (v/v) formic acid water solution, mobile phase B is 0.1% (v/v) formic acid acetonitrile solution, gradient elution procedure: 0-5.0min, 5%, 5.0-10.0min, 10%, 10.0-15.0min, 20%, 15.0-20.0min, 40%; flow rate 0.3mL/min, mass spectrometry ion mode: ESI source, in positive ion mode, ion source interface voltage: 4.0kV, gas flow rate: 10.0L/min, drying gas flow rate: 10.0L/min, heating gas flow rate: 10.0L/min; heating module temperature: 400 ℃, interface temperature: 300 ℃, scan mode: full scan mode (m/z 50-2000).
The amino acid sequence of the protein peptide obtained by sequencing is YYMEGDFAFGDNY, the molecular weight of the protein peptide is 1535.7Da, and the polypeptide is named as PA 1.
5. Detecting the anti-fatigue function of protein peptide
Selecting a male mouse with the weight of 18-22g, dividing the mouse into a blank control group and an experimental group, wherein the experimental group comprises a low-dose group, a medium-dose group and a high-dose group, the blank control group, the low-dose group, the medium-dose group and the high-dose group are all 10 mice, and feeding the mice with synthetic PA1 polypeptide respectively; the anti-fatigue swimming test of the mice is carried out. After a lead wire with the weight of 5% is loaded at the tail of the mouse, the lead wire is put into a water tank for swimming, the time that the mouse can not float out of the water surface (in a exhaustion state) from the time of entering the water to the time of sinking the mouse into the water is observed and recorded, the experimental water temperature is 25 ℃, and the water depth is 25 cm. The results of the experiment are shown in table 1 and fig. 3. The relevant data are recorded in table 1 and bar chart statistics are performed for each set of data, see fig. 3.
Table 1: table of the Effect of different doses of PA1 polypeptide on mouse weight-bearing swimming time (x. + -. s)
Group of | n | Dosage (mg/kg) | Exhaustion State time(s) |
Control group | 10 | - | 365.67±51.2 |
|
10 | 50 | 554.59±62.4 |
|
10 | 100 | 677.32±45.7 |
|
10 | 150 | 720.75±74.1 |
The experimental results showed that the time of the mice in the low dose group, the medium dose group and the high dose group was significantly prolonged in the exhaustion state (p <0.01) as compared with the control group, and thus it was found that the PA1 protein peptide was able to exert an anti-fatigue effect on the mice, and the medium dose group and the high dose group were significantly prolonged as compared with the low dose group, indicating that the anti-fatigue effect of the PA1 polypeptide had concentration dependency, but the 150mg/kg group did not significantly prolong the weight swimming time as compared with the 100mg/kg group.
Example 4: composition comprising protein peptide added to Chinese wolfberry fruit oil and walnut oil
Adding the protein peptide prepared in the example 3 into a solvent to prepare a product with an anti-fatigue function, wherein the solvent comprises medlar fruit oil and walnut oil;
one specific article is prepared as follows:
1) mixing 2 parts of medlar oil, 3 parts of walnut oil and 10 parts of water, and stirring to prepare a solvent;
2) adding the protein peptide into the solvent at a concentration of 20-65 μ g/ml.
Furthermore, the solvent is also added with a flavoring agent for improving taste, which is a sweetening agent or an acidulant.
The invention adds the protein peptide with the anti-fatigue function into the solvent prepared from the medlar fruit oil and the walnut oil, so that the prepared edible product has the efficacy of resisting asthenopia and also has the effect of relieving fatigue.
The above examples are only intended to illustrate the technical solution of the present invention, but not to limit it; although the present invention has been described in detail with reference to the foregoing embodiments, it will be understood by those of ordinary skill in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some technical features may be equivalently replaced; and such modifications or substitutions do not depart from the spirit and scope of the present invention.
Claims (10)
1. The composition of the medlar fruit oil and the walnut oil is characterized by comprising the medlar fruit oil and the walnut oil in any proportion.
2. The composition of wolfberry fruit oil and walnut oil as claimed in claim 1, wherein the composition further comprises an anti-fatigue protein peptide.
3. The composition of wolfberry fruit oil and walnut oil as claimed in claim 2, wherein the said anti-fatigue protein peptide is obtained by centrifuging the enzymatic hydrolysate of alcalase2.4 and trypsin of tuna meat.
4. The composition of wolfberry fruit oil and walnut oil as claimed in claim 3, wherein the enzymolysis temperature of the enzymolysis solution is 35 ℃ for 5-6 h.
5. The composition of Lycium barbarum fruit oil and walnut oil of claim 3, wherein the ratio of Alcalase2.4 enzyme to trypsin enzyme activity is 1: 3.
6. The composition of Lycium barbarum fruit oil and walnut oil as claimed in claim 2, wherein the molecular weight of the protein peptide is 500-3000 Da.
7. The composition of wolfberry fruit oil and walnut oil as claimed in claim 6, wherein the protein peptide has the amino acid sequence of YYMEGDFAFGDNY.
8. The composition of Lycium barbarum fruit oil and walnut oil and its use of claim 1, wherein said composition further comprises conventional flavoring agents.
9. The composition of lycium barbarum fruit oil and walnut oil and its use according to claim 8, wherein the seasoning is a sweetener or an acidulant.
10. Use of a composition prepared by the process of any one of claims 1 to 9 in an anti-fatigue article.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111509884.XA CN114158621B (en) | 2021-12-10 | 2021-12-10 | A composition containing oleum Lycii and oleum Juglandis and its application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111509884.XA CN114158621B (en) | 2021-12-10 | 2021-12-10 | A composition containing oleum Lycii and oleum Juglandis and its application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114158621A true CN114158621A (en) | 2022-03-11 |
CN114158621B CN114158621B (en) | 2024-03-26 |
Family
ID=80485501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111509884.XA Active CN114158621B (en) | 2021-12-10 | 2021-12-10 | A composition containing oleum Lycii and oleum Juglandis and its application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114158621B (en) |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1297754A (en) * | 1999-11-26 | 2001-06-06 | 云南金碧制药厂 | Tonic food capable of lowering blood lipoid, resisting senility and regulating immunity |
CN101280327A (en) * | 2008-05-26 | 2008-10-08 | 昆明理工大学 | Synchronous aqueous enzymatic ultrasonic extraction for walnut oil and walnut protein peptide |
CN101757096A (en) * | 2008-10-22 | 2010-06-30 | 高秀珍 | Brain boosting oral liquid |
CN101962596A (en) * | 2010-09-17 | 2011-02-02 | 昆明理工大学 | Method for synchronously preparing walnut oil and walnut peptide |
CN102342407A (en) * | 2011-09-30 | 2012-02-08 | 华南理工大学 | Anti-fatigue drink and preparation method thereof |
CN103444911A (en) * | 2012-06-05 | 2013-12-18 | 张伟伟 | Medicinal and edible health care blending oil |
CN105087730A (en) * | 2015-08-14 | 2015-11-25 | 浙江省海洋开发研究院 | High-F (Fischer)-value tuna oligopeptide preparation method |
CN105146045A (en) * | 2015-09-22 | 2015-12-16 | 华南理工大学 | Method for using ocean fish protein and freshwater fish protein for preparing combined antihypertensive peptides |
CN105254737A (en) * | 2015-11-10 | 2016-01-20 | 浙江海洋学院 | Swim bladder collagen anti-oxidation and anti-fatigue protein peptide |
CN105341185A (en) * | 2015-11-11 | 2016-02-24 | 成都圣弘源生物科技有限公司 | Composite nutritional blend oil and preparation method thereof |
CN105361168A (en) * | 2015-12-02 | 2016-03-02 | 绥化学院 | Composite antioxidation peptides and preparation method thereof |
CN105410945A (en) * | 2015-11-10 | 2016-03-23 | 浙江海洋学院 | Application of collagen peptide of slim bladders |
CN106995747A (en) * | 2017-06-14 | 2017-08-01 | 中国科学院兰州化学物理研究所 | A kind of air-flow ultramicro grinding and the method for ultrasonic subcritical abstraction combined extracting fructus lycii oil |
CN107821726A (en) * | 2017-10-25 | 2018-03-23 | 浦江县欧立生物技术有限公司 | The purposes of grass carp anti-fatigue active peptide |
CN112868957A (en) * | 2021-01-27 | 2021-06-01 | 武汉名实生物医药科技有限责任公司 | Compound hydrolyzed peptide beverage for enhancing immunity and resisting fatigue |
-
2021
- 2021-12-10 CN CN202111509884.XA patent/CN114158621B/en active Active
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1297754A (en) * | 1999-11-26 | 2001-06-06 | 云南金碧制药厂 | Tonic food capable of lowering blood lipoid, resisting senility and regulating immunity |
CN101280327A (en) * | 2008-05-26 | 2008-10-08 | 昆明理工大学 | Synchronous aqueous enzymatic ultrasonic extraction for walnut oil and walnut protein peptide |
CN101757096A (en) * | 2008-10-22 | 2010-06-30 | 高秀珍 | Brain boosting oral liquid |
CN101962596A (en) * | 2010-09-17 | 2011-02-02 | 昆明理工大学 | Method for synchronously preparing walnut oil and walnut peptide |
CN102342407A (en) * | 2011-09-30 | 2012-02-08 | 华南理工大学 | Anti-fatigue drink and preparation method thereof |
CN103444911A (en) * | 2012-06-05 | 2013-12-18 | 张伟伟 | Medicinal and edible health care blending oil |
CN105087730A (en) * | 2015-08-14 | 2015-11-25 | 浙江省海洋开发研究院 | High-F (Fischer)-value tuna oligopeptide preparation method |
CN105146045A (en) * | 2015-09-22 | 2015-12-16 | 华南理工大学 | Method for using ocean fish protein and freshwater fish protein for preparing combined antihypertensive peptides |
CN105254737A (en) * | 2015-11-10 | 2016-01-20 | 浙江海洋学院 | Swim bladder collagen anti-oxidation and anti-fatigue protein peptide |
CN105410945A (en) * | 2015-11-10 | 2016-03-23 | 浙江海洋学院 | Application of collagen peptide of slim bladders |
CN105341185A (en) * | 2015-11-11 | 2016-02-24 | 成都圣弘源生物科技有限公司 | Composite nutritional blend oil and preparation method thereof |
CN105361168A (en) * | 2015-12-02 | 2016-03-02 | 绥化学院 | Composite antioxidation peptides and preparation method thereof |
CN106995747A (en) * | 2017-06-14 | 2017-08-01 | 中国科学院兰州化学物理研究所 | A kind of air-flow ultramicro grinding and the method for ultrasonic subcritical abstraction combined extracting fructus lycii oil |
CN107821726A (en) * | 2017-10-25 | 2018-03-23 | 浦江县欧立生物技术有限公司 | The purposes of grass carp anti-fatigue active peptide |
CN112868957A (en) * | 2021-01-27 | 2021-06-01 | 武汉名实生物医药科技有限责任公司 | Compound hydrolyzed peptide beverage for enhancing immunity and resisting fatigue |
Non-Patent Citations (4)
Title |
---|
古世阳等: "金枪鱼肽制备工艺与功效研究进展", 广州化工, vol. 49, no. 18, pages 1 - 2 * |
李淑凡等: "金枪鱼红肉酶解液对小鼠抗疲劳和调节肠道菌群效果的研究", 食品工业科技, vol. 40, no. 17, pages 314 - 320 * |
王思远;张业辉;黄利华;张友胜;汪婧瑜;: "鱼蛋白肽的制备及其作为功能食品基料的应用", 广州城市职业学院学报, no. 02, pages 54 - 58 * |
程芬芬;朱江;龙彩云;陈红兵;杨安树;: "酶水解技术在鱼下脚料加工中的应用", 食品工业科技, no. 24, pages 426 - 429 * |
Also Published As
Publication number | Publication date |
---|---|
CN114158621B (en) | 2024-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5793176B2 (en) | Method for preparing a sweetening composition containing a terpene glycoside | |
US20210274822A1 (en) | Method for preparing luo han guo sweetening composition from siraitia grosvenorii and use thereof | |
EP2288716B1 (en) | Method for producing corn gluten hydrolysate and corn gluten hydrolysate using the same | |
CN105063139B (en) | It is a kind of for the preparation method for the seabuckthorn seeds polypeptide sobered up | |
CN103524596B (en) | Antioxidative peptide of shark protein as well as preparation method and use thereof | |
CN107898868B (en) | Method for synchronously separating and preparing lycium erythrophyll, lycium barbarum polysaccharide and lycium barbarum flavone from lycium barbarum | |
CN108276465B (en) | Method for separating and purifying mogroside V by subcritical water desorption technology | |
CN109777849B (en) | Preparation method for extracting proteolysis polypeptide from debitterized peach kernel | |
CN113854533A (en) | Method for preparing mogroside, momordica grosvenori phenolic acid and momordica grosvenori concentrated juice from fresh momordica grosvenori | |
CN109170532A (en) | A kind of preparation method and application of Semen Coicis extract | |
CN114158621B (en) | A composition containing oleum Lycii and oleum Juglandis and its application | |
CN111072752B (en) | Preparation method of polypeptide capable of promoting human skin cell proliferation, product and application thereof | |
CN105907826B (en) | Clean preparation method of plant polypeptide/protein | |
CN108095117A (en) | Gadol extract and its extracting method and application | |
CN104054850A (en) | Method for removing bitterness of linseed oil by enzymatic process | |
CN112266399A (en) | High-purity separation and extraction method of epimedium extract | |
US11865131B2 (en) | Anthocyanin powder extract and process for production | |
KR20210074526A (en) | A high efficiency extraction method of phyllodulcin from Hydrangea serrata using supercritical extraction | |
JP4677393B2 (en) | Purified gardenia extract | |
CN113881744B (en) | Method for preparing salty peptide by subcritical water assisted enzymolysis of gluten protein | |
CN115028682A (en) | Salt-increasing peptide from dry-cured ham and preparation method thereof | |
JP3806693B2 (en) | Method for recovering pinitol from soybean processing by-products in high yield | |
CN107915772A (en) | A kind of new sweet potato glycoprotein and the sweet potato glycoprotein extract comprising the sweet potato glycoprotein | |
CN110218754A (en) | A kind of preparation method of anti-oxidation peptide | |
CN107212324B (en) | Method for preparing reconstituted pomelo fruit powder from degraded pomelo juice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |